TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Profusa ( (PFSA) ) has shared an update.
On August 19, 2025, Profusa announced the appointment of Peter O’Rourke, former Acting U.S. Secretary of Veterans Affairs, as Lead Independent Director, and Fred Knechtel, a seasoned financial executive, as CFO. These leadership changes come as Profusa prepares to commercialize its biosensor platform, aiming to enhance its market position and drive growth. O’Rourke’s extensive experience in healthcare systems and Knechtel’s financial expertise are expected to strengthen Profusa’s path to commercialization and maximize shareholder value.
More about Profusa
Profusa, Inc., based in Berkeley, California, is a commercial stage digital health company focused on developing tissue-integrated sensors for continuous biochemical monitoring. The company aims to provide personalized, actionable medical-grade data through its biosensors and intelligent data platform.
Average Trading Volume: 5,640,545
Technical Sentiment Signal: Sell
Current Market Cap: $16.37M
Learn more about PFSA stock on TipRanks’ Stock Analysis page.